GGTI-2418
CAS No. 501010-06-6
GGTI-2418 ( —— )
产品货号. M32935 CAS No. 501010-06-6
GGTI-2418 是一种高效,竞争性和选择性的香叶基香叶基转移酶 I (GGTase I) 抑制剂。GGTI-2418 抑制 GGTase I 和 FTase 活性,IC50 分别为 9.5 nM 和 53 μM。GGTI-2418 还增强 p27(Kip1) 并诱导乳腺肿瘤显着消退。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥1102 | 有现货 |
|
| 10MG | ¥1786 | 有现货 |
|
| 25MG | ¥3469 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥1207 | 有现货 |
|
生物学信息
-
产品名称GGTI-2418
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述GGTI-2418 是一种高效,竞争性和选择性的香叶基香叶基转移酶 I (GGTase I) 抑制剂。GGTI-2418 抑制 GGTase I 和 FTase 活性,IC50 分别为 9.5 nM 和 53 μM。GGTI-2418 还增强 p27(Kip1) 并诱导乳腺肿瘤显着消退。
-
产品描述GGTI-2418 is a highly potent, competitive, and selective geranylgeranyltransferase I (GGTase I) inhibitor. GGTI-2418 inhibits GGTase I and FTase activities with IC50s of 9.5 nM and 53 μM, respectively. GGTI-2418 also increases p27(Kip1) and induces significant regression of breast tumors.
-
体外实验GGTI-2418 inhibits GGTase I and FTase activities with IC50s of 9.5±2.0 nM and 53±11 μM, respectively, a 5,600-fold selectivity toward inhibition of GGTase I versus FTase. GGTI-2418 demonstrates competitive inhibition of GGTase I against the H-Ras-CVLL protein with a Ki of 4.4±1.6 nM.GGTi-2418 (10-15 μM; 16 hours) treatment delocalizes FBXL2 and stabilizes IP3R3.Western Blot Analysis Cell Line:HeLa cells Concentration:10-15 μM Incubation Time:16 hours Result:Delocalized FBXL2 and stabilized IP3R3.
-
体内实验GGTI-2418 (100 mg/kg daily or 200 mg/kg every third day; 15 days) significantly inhibits the growth of breast tumor xenografts in nude mice with MDA-MB-231 xenografts.GGTI-2418 (100 mg/kg daily; 5 days) induces regression of ErbB2-driven mammary tumors in ErbB2 transgenic mice. GGTI-2418 inhibits the geranylgeranylation of Rap1 and causes a dramatic decrease in S473 phosphorylation of Akt. GGTI-2418 also upregulates p27 levels in vivo.Animal Model:Nude mice implanted with MDA-MB-231 breast cancer tumors Dosage:100 mg/kg daily or 200 mg/kg every third day Administration:Injected intraperitoneally; 15 days Result:Inhibited the growth of breast tumor xenografts.Animal Model:ErbB2 transgenic mice Dosage:100 mg/kg/day Administration:Subcutaneously; 5 days Result:Halted tumor growth and induced massive tumor regression. Tumor decreased by 76% following GGTI-2418 treatment.
-
同义词——
-
通路Metabolic Enzyme/Protease
-
靶点Transferase
-
受体Transferase
-
研究领域——
-
适应症——
化学信息
-
CAS Number501010-06-6
-
分子量441.52
-
分子式C23H31N5O4
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO 中的溶解度 : 125 mg/mL (283.11 mM; 超声助溶 )
-
SMILESCC(C)C[C@H](NC(=O)N1CCN(Cc2nc[nH]c2C)C(=O)[C@@H]1Cc1ccccc1)C(O)=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Kazi A, et al. Blockade of protein geranylgeranylation inhibits Cdk2-dependent p27Kip1 phosphorylation on Thr187 and accumulates p27Kip1 in the nucleus: implications for breast cancer therapy. Mol Cell Biol. 2009 Apr;29(8):2254-63.?
产品手册
关联产品
-
Minodronic acid mono...
米诺膦酸一水合物是一种法尼基二磷酸合成酶抑制剂,可作为骨吸收抑制剂。
-
Opicapone
Opicapone 降低细胞的 ATP 含量(IC50:98 μM)。
-
3,5-Dinitrocatechol
OR-486 是儿茶酚-O-甲基-转移酶 (COMT) 的抑制剂,可用于制备钼 (VI)- 3,5-二硝基儿茶酚复合物。
021-51111890
购物车()
sales@molnova.cn

